Re: Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in
a cohort of 3546 women prospectively followed long term after reconstruction with
textured breast implants
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Implant surface options and biofilm mitigation strategies.Plast Reconstr Surg. 2019; 144: 13S
- ASJ special topic: betadine and breast implants.Aesth Surg J. 2018; 38: 623-626
- Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants.Plast Reconstr Surg. 2017; 140: 427
Article info
Publication history
Published online: September 16, 2020
Accepted:
August 1,
2020
Received:
June 9,
2020
Journal of Plastic, Reconstructive & Aesthetic Surgery (2020) 73, 841–846Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2020 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implantsJournal of Plastic, Reconstructive & Aesthetic SurgeryVol. 73Issue 5
- PreviewThe risk of BIA-ALCL for patients with textured breast implants has been estimated between 1/2832 and 1/30,000 women. Existing studies estimating the numbers exposed and at risk, may have under reported cases, and/or lacked comprehensive follow-up. Our objective is to determine the risk of BIA-ALCL in a defined cohort of patients reconstructed with macro-textured breast implants and consistently followed long-term.
- Full-Text
- Preview
